Home » Stocks » XYNO

Xynomic Pharmaceutical Holdings Inc. (XYNO)

Stock Price: $2.41 USD 0.00 (0.00%)
Updated Jan 15, 2021 9:30 AM EST - Market closed
Market Cap 111.52M
Revenue (ttm) n/a
Net Income (ttm) -26.80M
Shares Out 32.28M
EPS (ttm) -4.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $2.41
Previous Close $2.41
Change ($) 0.00
Change (%) 0.00%
Day's Open 2.41
Day's Range 2.41 - 2.41
Day's Volume 0
52-Week Range 0.2 - 3.5

News

There are no news available yet.

About XYNO

Xynomic Pharmaceuticals Holdings, a clinical stage biopharmaceutical company, discovers and develops small molecule drug candidates for the treatment of cancer in the People's Republic of China and the United states. Its lead drug candidate is Abexinostat, an orally dosed hydroxamic acid-based small molecule histone deacetylase inhibitor. The company develops pazopanib a molecular therapy for treating renal cell carcinoma; XYN-603 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory (R/R) mantle cell lymphoma or R/R... [Read more...]

Industry
Biotechnology
Founded
2016
CEO
Yinglin Xu
Employees
27
Stock Exchange
OTCMKTS
Ticker Symbol
XYNO
Full Company Profile

Financial Performance

Financial Statements